Antonello, C. (1999) Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect (letter). Journal of Psychiatry and Neuroscience, 24, 250.
Baum, B. (1993) Principles of saliva secretion in saliva as a novel diagnostic fluid. Annals of the NewYork Academy of Science, 694, 17–23.
Ben-Aryeh, H., Jungerman, T., Szargel, R., et al (1996) Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biological Psychiatry, 39, 946–949.
Berlan, M., Montrstruc, J. & Lafontan, M. (1992) Pharmacological prospects for alpha 2 adrenoceptor antagonist therapy. Trends in Pharmacological Science, 13, 277–282.
Calderon, , Robin, E. & Sobota, W. L. (2000) Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report. International Clinical Psychopharmacology, 15, 49–52.
Copp, P. J., Lament, R. & Tennent, T. G. (1991) Amitriptyline in clozapine-induced sialorrhoea (letter). British Journal of Psychiatry, 159, 166.
Corrigan, F. M. & Macdonald, S. (1995) Clozapine-induced hypersalivation and the alpha 2 adrenoceptor (letter). British Journal of Psychiatry, 167, 412.
Fritz, J. & Tilmann, E. (1995) Pirenzepine for clozapine-induced hypersalivation (letter). Lancet, 346, 1034.
Grabowski, J. (1992) Clonidine treatment of clozapine-induced hypersalivation (letter), Journal of Clinical Psychopharmacology, 12, 69–70.
Mandel, J., Zengo, A., Katz, R., et al (1975) Effects of adrenergic agents on salivary composition. Journal of Dental Research, 54, B27–B33.
McCarthy, R. & Terkelsen, K. (1994) Oesophageal dysfunction in two patients after clozapine treatment. Journal of Clinical Psychopharmacology, 14, 281–283.
Rabinowitz, T., Frankenberg, F., Centorrino, F., et al (1996) The effect of clozapine on saliva flow rate: a pilot study. Biological Psychiatry, 40, 1132–1134.
Reinstein, M., Sirotovskya, L., Chasonov, M., et al (1999) Comparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapine. Clinical Drug Investigation, 17, 97–102.
Safferman, A., Liberman, J., Kane, M., et al (1991) Update on the clinical efficacy and side effects of clozapine. Schizophrenia Bulletin, 17, 247–261.
Spivak, B., Adlersberg, S., Rosen, L., et al (1997) Trihexyphenidyl treatment of clozapine induced hypersalivation. International Clinical Psychopharmacology
Ukai, Y., Taniguchi, T. & Kimura, K. (1989) Muscarinic supersensitivity and subsensitivity induced by chronic treatment with atropine and disopylfluorophosphate in rat submaxillary glands. Archives of International Pharmacodynamic Therapy, 6, 148–157.
Zorn, S., Jones, S., Ward, K., et al (1994) Clozapine is a potent and selective muscarinic M4 receptor agonist. European Journal of Pharmacology, 269, R1–R2.